Search

Your search keyword '"Witzenbichler, B."' showing total 332 results

Search Constraints

Start Over You searched for: Author "Witzenbichler, B." Remove constraint Author: "Witzenbichler, B."
332 results on '"Witzenbichler, B."'

Search Results

1. Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice:: GLORIA-AF Registry

5. Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type

7. Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry

14. Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events after Percutaneous Coronary Intervention: The PARIS Registry

16. The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

17. Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type

18. P511Incidence and patterns of dual antiplatelet therapy cessation among patients with peripheral arterial disease after percutaneous coronary intervention: insights the PARIS registry

19. The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

20. Incidence and Potential Mechanism of Resolved, Persistent and Newly Acquired Malapposition 3 days after Implantation of Self-expanding or Balloon-expandable Stent in STEMI population: insights from Optical Coherence Tomography in the Apposition II study

21. Self-Expanding Versus Balloon-Expandable Stents in Acute Myocardial Infarction: Results From the APPOSITION II Study Self-Expanding Stents in ST-Segment Elevation Myocardial Infarction

23. Effect of paclitaxel elution from reservoirs with bioabsorbable polymer compared to a bare metal stent for the elective percutaneous treatment of de novo coronary stenosis: the EUROSTAR-II randomised clinical trial

24. Effect of paclitaxel elution from reservoirs with bioabsorbable polymer compared to a bare metal stent for the elective percutaneous treatment of de novo coronary stenosis: The EUROSTAR-II randomised clinical trial

25. Six-month clinical and angiographic results of the STENTYS® self-apposing stent in bifurcation lesions

26. Impact of transfer for primary percutaneous coronary intervention on survival and clinical outcomes (from the HORIZONS-AMI Trial).

27. A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-Month follow-up results of the EXCELLA II study

28. First-in-man (FIM) study of the Stentys™ bifurcation stent - 30 days results

29. Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy

30. Mouse model of angiogenesis

31. Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial

36. Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial.

38. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction.

39. Incidence, mechanisms, predictors, and clinical impact of acute and late stent malapposition after primary intervention in patients with acute myocardial infarction: an intravascular ultrasound substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial.

40. Volumetric intravascular ultrasound analysis of Paclitaxel-eluting and bare metal stents in acute myocardial infarction: the harmonizing outcomes with revascularization and stents in acute myocardial infarction intravascular ultrasound substudy.

43. Ostiumplastik des linken Hauptstammes.

45. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2.

46. Comparison of fondaparinux and enoxaparin in acute coronary syndromes

47. Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type

48. Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction.

50. Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation. the GLORIA-AF registry

Catalog

Books, media, physical & digital resources